Antibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 11820-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- SDC4 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated SDC4 antibody (Cat. #11820-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Spatial and single-cell colocalisation analysis reveals MDK-mediated immunosuppressive environment with regulatory T cells in colorectal carcinogenesis.
Endothelial CXCR2 deficiency attenuates renal inflammation and glycocalyx shedding through NF-κB signaling in diabetic kidney disease.
Bioinformatics analysis identifies heparan sulfate proteoglycans acting as different progress subtypes of biliary atresia.
Cadherin-16 inhibits thyroid carcinoma cell proliferation and invasion.
Atypical E3 ligase ZFP91 promotes small-molecule-induced E2F2 transcription factor degradation for cancer therapy.
Therapeutic potential of targeting membrane-spanning proteoglycan SDC4 in hepatocellular carcinoma.
Dioscin Inhibits HSC-T6 Cell Migration via Adjusting SDC-4 Expression: Insights from iTRAQ-Based Quantitative Proteomics.
Hashimoto M, Kojima Y, Sakamoto T, Ozato Y, Nakano Y, Abe T, Hosoda K, Saito H, Higuchi S, Hisamatsu Y, Toshima T, Yonemura Y, Masuda T, Hata T, Nagayama S, Kagawa K, Goto Y, Utou M, Gamachi A, Imamura K, Kuze Y, Zenkoh J, Suzuki A, Takahashi K, Niida A, Hirose H, Hayashi S, Koseki J, Fukuchi S, Murakami K, Yoshizumi T, Kadomatsu K, Tobo T, Oda Y, Uemura M, Eguchi H, Doki Y, Mori M, Oshima M, Shibata T, Suzuki Y, Shimamura T, Mimori K
EBioMedicine 2024 May;103:105102
EBioMedicine 2024 May;103:105102
Endothelial CXCR2 deficiency attenuates renal inflammation and glycocalyx shedding through NF-κB signaling in diabetic kidney disease.
Cui S, Chen X, Li J, Wang W, Meng D, Zhu S, Shen S
Cell communication and signaling : CCS 2024 Mar 25;22(1):191
Cell communication and signaling : CCS 2024 Mar 25;22(1):191
Bioinformatics analysis identifies heparan sulfate proteoglycans acting as different progress subtypes of biliary atresia.
Ding Z, Song W, Zhu W, Xie H, Zhu Z, Tang W
Frontiers in pediatrics 2023;11:1065521
Frontiers in pediatrics 2023;11:1065521
Cadherin-16 inhibits thyroid carcinoma cell proliferation and invasion.
Yang X, Li Y, Liu G, Zha W, Liu Y
Oncology letters 2022 May;23(5):145
Oncology letters 2022 May;23(5):145
Atypical E3 ligase ZFP91 promotes small-molecule-induced E2F2 transcription factor degradation for cancer therapy.
Liu TT, Yang H, Zhuo FF, Yang Z, Zhao MM, Guo Q, Liu Y, Liu D, Zeng KW, Tu PF
EBioMedicine 2022 Dec;86:104353
EBioMedicine 2022 Dec;86:104353
Therapeutic potential of targeting membrane-spanning proteoglycan SDC4 in hepatocellular carcinoma.
Yang H, Liu Y, Zhao MM, Guo Q, Zheng XK, Liu D, Zeng KW, Tu PF
Cell death & disease 2021 May 14;12(5):492
Cell death & disease 2021 May 14;12(5):492
Dioscin Inhibits HSC-T6 Cell Migration via Adjusting SDC-4 Expression: Insights from iTRAQ-Based Quantitative Proteomics.
Yin L, Qi Y, Xu Y, Xu L, Han X, Tao X, Song S, Peng J
Frontiers in pharmacology 2017;8:665
Frontiers in pharmacology 2017;8:665
No comments: Submit comment
No validations: Submit validation data